Larvol Delta - Samuraciclib-for-the-Treatment-of-Patients-With-Resectable-Borderline-Resectable-or-Locally-Advanced-Basal-Pancreatic-Cancer

samuraciclib (CT7001) - Carrick Therap

http://clinicaltrials.gov/ct2/show/NCT07645651

Jul 14, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next